Metabolic evaluation and medical management of upper urinary tract stone disease. Guidelines from the Scandinavian Cooperative Group for Urinary Stones.
A set of simple guidelines for metabolic evaluation and medical/dietary management of patients with urolithiasis is presented. The evaluation scheme is based on the documented risk factors in the Nordic area and the results of controlled clinical trials, and takes its basis in the severity of the stone disease in the individual stone patient. The initial evaluation in all patients aims at diagnosing conditions with a definitive metabolic, infectious or anatomical/functional cause of stone formation (MIAF urolithiasis). Patients with MIAF urolithiasis are treated according to the nature of the underlying disease. Having excluded/diagnosed MIAF urolithiasis, patients with idiopathic calcium nephrolithiasis remain, and in this group, which comprises approximately 85% of the total stone population in the Scandinavian region, only those with a complicated stone disease are subjected to additional evaluation, which aims at identifying underlying pathophysiological derangements for which medical therapy has been proven to be effective in controlled clinical trials.
Osther
P J
PJ
Department of Urology, Odense University Hospital, Denmark. palle.osther@dadlnet.dk
Grenabo
L
L
Haraldsson
G
G
Holmberg
G
G
Lindell
O
O
Mogensen
P
P
Schultz
A
A
Ulvik
N M
NM
D004044:Dietary Proteins / Q000008:administration & dosage; D006801:Humans; D008659:Metabolic Diseases / Q000150:complications; D008661:Metabolism, Inborn Errors / Q000150:complications; D014545:Urinary Calculi / Q000209:etiology / Q000378:metabolism* / Q000517:prevention & control*; D014552:Urinary Tract Infections / Q000150:complications
D004044:Dietary Proteins